头颈鳞癌颈清扫术后引流液生物标志物初探
结果显示CXCL-12在淋巴结转移、结外延伸(ENE)和切缘近时显著升高,骨桥蛋白在ENE时显著升高而TGF-β显著降低;多因素分析中CXCL-2是预测切缘近的唯一独立因素。提示引流液可能成为术后相关信息来源,但结论需进一步研究验证。
要点
- 骨桥蛋白在ENE时显著升高,TGF-β在ENE时显著降低。
- 多因素分析中CXCL-2是预测切缘近的唯一独立因素。
核心结论
- 这项预试验提示伤口引流液可能作为头颈鳞癌患者术后相关信息的潜在来源。
- CXCL-12、骨桥蛋白和TGF-β在引流液中的表达与淋巴结转移、ENE或切缘近相关,但其预后影响需进一步研究确认。
研究设计与样本
- 术后第1–3天用ELISA试剂盒检测伤口引流液中生物标志物表达,并与临床和病理特征相关分析。
主要发现
- CXCL-12在存在淋巴结转移、ENE和切缘近时于引流液中显著升高。
- 骨桥蛋白在存在ENE时显著升高,TGF-β检测在ENE时显著降低。
- 多因素分析中,术后第1天和第3天CXCL-2水平是预测切缘近的唯一保留显著性的因素(第1天p=0.028,第3天p=0.025)。
- CXCL-2和骨桥蛋白检测均与ENE显著相关(第1天p=0.018和0.035;第3天p=0.052和0.025),TGF-β仅在术后第1天显著(p=0.038)。
关键数值与推荐
- CXCL-2预测切缘近:术后第1天p=0.028,第3天p=0.025。
- CXCL-2与ENE相关:第1天p=0.018,第3天p=0.052。
- 骨桥蛋白与ENE相关:第1天p=0.035,第3天p=0.025。
- TGF-β与ENE相关:仅第1天p=0.038。
临床怎么用
- 该预试验结果尚不能直接指导临床决策,引流液生物标志物检测目前仅具研究价值。
- 未来或可探索引流液CXCL-12、骨桥蛋白、TGF-β和CXCL-2用于术后风险分层,但需进一步验证。
局限性
- 仅检测术后第1–3天引流液,随访和预后影响未报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: In a pilot prospective study, we aimed to test the feasibility and report on the preliminary results on the expression of molecular biomarkers in wound drainage fluids (WDFs) of operated head and neck squamous cell carcinoma (HNSCC) patients. MATERIAL AND METHODS: Nineteen patients undergoing primary tumor resection with en-block neck dissection were enrolled. In postoperative days 1-3, the expression of several biomarkers in WDFs was measured using enzyme-linked immunosorbent assay (ELISA) kits and correlated with clinical and histopathologic features. RESULTS: The expression of stromal cell-derived factor 1 (CXCL-12) was significantly increased in WDFs in presence of lymph node metastases, extranodal extension (ENE), and in case of close resection margins. In addition, Osteopontin expression was significantly increased in presence of ENE, whereas transforming growth factor beta (TGF-β) detection was significantly reduced. At multivariate analysis, CXCL-2 levels in both day 1 and 3 post-surgery were the only factor which retained significance in the prediction of close surgical margins (p = 0.028 and 0.025 for day 1 and day 3, respectively). Both CXCL-2 and Ostepontin assays were significantly correlated with ENE (p = 0.018 and 0.035 for day 1; 0.052 and 0.025 for day 3, respectively) whereas TGF- β expression was significant at day 1 only (p = 0.038). CONCLUSIONS: Our pilot study showed that WDFs could qualify as a potential source of relevant postoperative information. Further studies are needed to confirm the prognostic impact of CXCL-12, Osteopontin and TGF-β expressed in WDFs on the personalized management of HNSCC.
引用
- Gualtieri T, Bonomo P, Sottili M, et al. Biomarkers in wound drainage fluids of head and neck squamous cell carcinoma patients receiving neck dissection: A pilot study. Clin Transl Radiat Oncol. 2020. PMID: 32435703. doi:10.1016/j.ctro.2020.04.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。